Early research (Phase 1)Ended earlyNCT02313012What this trial is testingSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsWho this might be right forNeoplasm Metastasis Celgene 19
Testing effectiveness (Phase 2)Study completedNCT00313794What this trial is testingStudy of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After TreatmentWho this might be right forColorectal Neoplasms AstraZeneca 49
Testing effectiveness (Phase 2)Study completedNCT03206073What this trial is testingA Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal CancerWho this might be right forColorectal CancerColorectal CarcinomaColorectal Adenocarcinoma+2 more National Cancer Institute (NCI) 34
Early research (Phase 1)Looking for participantsNCT05433142What this trial is testingStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Xencor, Inc. 307
Early research (Phase 1)Looking for participantsNCT06102902What this trial is testingTesting the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal CancerWho this might be right forMetastatic Colorectal AdenocarcinomaRecurrent Colorectal AdenocarcinomaRefractory Colorectal Adenocarcinoma+1 more National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT01285102What this trial is testingChemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerWho this might be right forLiver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more Fox Chase Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT00006103What this trial is testingCombination Chemotherapy in Treating Patients With Colorectal CancerWho this might be right forColorectal Cancer Alliance for Clinical Trials in Oncology 400
Testing effectiveness (Phase 2)Study completedNCT02393755What this trial is testingNintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal CancerWho this might be right forColon AdenocarcinomaRectal AdenocarcinomaRecurrent Colon Carcinoma+5 more Roswell Park Cancer Institute 42
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT03442569What this trial is testingPhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRCWho this might be right forColon Cancer UNC Lineberger Comprehensive Cancer Center 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04963283What this trial is testingStudy of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal CancerWho this might be right forColorectal AdenocarcinomaColon CancerColon Adenocarcinoma+4 more University of Colorado, Denver 48
Early research (Phase 1)Study completedNCT00379132What this trial is testing131-I-TM-601 Study in Adults With Solid TumorsWho this might be right forBreast CancerNon-Small Cell Lung CancerMelanoma+5 more TransMolecular 60
Testing effectiveness (Phase 2)Looking for participantsNCT07130903What this trial is testingAmplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Adenocarcinoma Barbara Ann Karmanos Cancer Institute 102
Not applicableStudy completedNCT05869097What this trial is testingTrifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Adenocarcinoma Hunan Cancer Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT05733000What this trial is testingCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Colorectal CarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma+30 more Northwestern University 94
Testing effectiveness (Phase 2)Study completedNCT02368886What this trial is testingLower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal CancerWho this might be right forColon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more Academic and Community Cancer Research United 123
Testing effectiveness (Phase 2)Looking for participantsNCT04851119What this trial is testingTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsWho this might be right forColorectal CarcinomaEndometrial CarcinomaMelanoma+19 more Children's Oncology Group 147
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625What this trial is testingTalimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Study completedNCT03436563What this trial is testingM7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite InstabilityWho this might be right forColon AdenocarcinomaHigh-Frequency Microsatellite InstabilityMetastatic Malignant Solid Neoplasm+8 more M.D. Anderson Cancer Center 4